ATYR·002120202·US·equity·Healthcare - Biotechnology-13D/G
ATYR (ATYR PHARMA INC) is held by 70 institutional investors as of Q1 2026. Largest holders: FMR LLC ($11.5M), FEDERATED HERMES, INC. ($8.2M), BlackRock, Inc. ($5M). Net institutional sentiment: Mixed.
See how ATYR's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer